Nalaganje...

Therapeutic approaches to slowing the progression of diabetic nephropathy – is less best?

OBJECTIVE: Angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors are known to reduce proteinuria and have been the first-line agents in the management of diabetic nephropathy for the past 20 years. This review covers recent studies that compare the benefit of add...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Vivian, Eva, Mannebach, Chelsea
Format: Artigo
Jezik:Inglês
Izdano: Just Medical Media Limited 2013
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3884747/
https://ncbi.nlm.nih.gov/pubmed/24432038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212249
Oznake: Označite
Brez oznak, prvi označite!